Cross-validation for nonlinear mixed effects models

被引:21
作者
Colby, Emily [1 ]
Bair, Eric [1 ,2 ]
机构
[1] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA
[2] Univ N Carolina, Dept Endodont, Chapel Hill, NC 27515 USA
基金
美国国家卫生研究院;
关键词
Cross-validation; Model selection; Nonlinear mixed effects; Population pharmacokinetic modeling; POPULATION PHARMACOKINETIC MODEL; THEOPHYLLINE; ELIMINATION; CHILDREN; OBESITY; NONMEM;
D O I
10.1007/s10928-013-9313-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cross-validation is frequently used for model selection in a variety of applications. However, it is difficult to apply cross-validation to mixed effects models (including nonlinear mixed effects models or NLME models) due to the fact that cross-validation requires "out-of-sample" predictions of the outcome variable, which cannot be easily calculated when random effects are present. We describe two novel variants of cross-validation that can be applied to NLME models. One variant, where out-of-sample predictions are based on post hoc estimates of the random effects, can be used to select the overall structural model. Another variant, where cross-validation seeks to minimize the estimated random effects rather than the estimated residuals, can be used to select covariates to include in the model. We show that these methods produce accurate results in a variety of simulated data sets and apply them to two publicly available population pharmacokinetic data sets.
引用
收藏
页码:243 / 252
页数:10
相关论文
共 29 条
  • [1] NEW LOOK AT STATISTICAL-MODEL IDENTIFICATION
    AKAIKE, H
    [J]. IEEE TRANSACTIONS ON AUTOMATIC CONTROL, 1974, AC19 (06) : 716 - 723
  • [2] Bailey J.M., 1996, Anesthesiology, V84, P288
  • [3] Pharmacogenetics and population pharmacokinetics: impact of the design on three tests using the SAEM algorithm
    Bertrand, Julie
    Comets, Emmanuelle
    Laffont, Celine M.
    Chenel, Marylore
    Mentre, France
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2009, 36 (04) : 317 - 339
  • [4] BOECKMANN AJ, 1992, NONMEM USERS GUIDE 5
  • [5] Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated?: A survey of the literature from 2002 to 2004
    Brendel, Karl
    Dartois, Celine
    Comets, Emmanuelle
    Lemenuel-Diot, Annabelle
    Laveille, Christian
    Tranchand, Brigitte
    Girard, Pascal
    Laffont, Celine M.
    Mentre, France
    [J]. CLINICAL PHARMACOKINETICS, 2007, 46 (03) : 221 - 234
  • [6] PHARMACOKINETICS OF COMPUTER-CONTROLLED ALFENTANIL ADMINISTRATION IN CHILDREN UNDERGOING CARDIAC-SURGERY
    FISET, P
    MATHERS, L
    ENGSTROM, R
    FITZGERALD, D
    BRAND, SC
    HSU, F
    SHAFER, SL
    [J]. ANESTHESIOLOGY, 1995, 83 (05) : 944 - 955
  • [7] Fitzmaurice G., 2011, Applied Longitudinal Data Analysis, V2nd
  • [8] GAL P, 1978, CLIN PHARMACOL THER, V23, P438
  • [9] Gibaldi M., 1982, Pharmacokinetics
  • [10] Selecting the best linear mixed model under REML
    Gurka, MJ
    [J]. AMERICAN STATISTICIAN, 2006, 60 (01) : 19 - 26